Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.

Sec. Clinical Microbiology

Volume 15 - 2025 | doi: 10.3389/fcimb.2025.1532257

This article is part of the Research Topic Application and Reliability Assessment of Next Generation Sequencing (NGS) and targeted NGS (tNGS) in the Diagnosis of Infectious Diseases-Volume III View all 38 articles

Identification of causative agents of infective endocarditis by metagenomic next-generation sequencing of resected valves

Provisionally accepted
Vladimir Lazarevic Vladimir Lazarevic 1*Nadia Gaïa Nadia Gaïa 1Truong-Thanh Pham Truong-Thanh Pham 2Mikaël De Lorenzi-Tognon Mikaël De Lorenzi-Tognon 1Myriam Girard Myriam Girard 1Florian Mauffrey Florian Mauffrey 1Yannick Charretier Yannick Charretier 1Gesuele Renzi Gesuele Renzi 3Christoph Huber Christoph Huber 4Jacques Schrenzel Jacques Schrenzel 2
  • 1 Genomic Research Laboratory, Department of Medicine, Geneva University Hospitals (HUG) and University of Geneva, Geneva, Switzerland
  • 2 Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals (HUG), Geneva, Switzerland
  • 3 Bacteriology Laboratory, Department of Diagnostics, Geneva University Hospitals (HUG), Geneva, Geneva, Switzerland
  • 4 Division of Cardiovascular Surgery, Department of Surgery, Geneva University Hospitals (HUG), Geneva, Switzerland

The final, formatted version of the article will be published soon.

    Background: Infective endocarditis (IE) is a rare and life-threatening condition with considerable mortality rates. Diagnosis is often complicated by negative blood culture results, limiting the accurate identification of causative pathogens. This study aimed to evaluate the effectiveness of metagenomic next-generation sequencing (mNGS) of cardiac valve specimens compared to conventional clinical laboratory methods for identifying pathogens in IE.Methods: Nineteen patients with suspected IE who were scheduled for surgical valve removal were prospectively enrolled. The metagenomic workflow included bacterial DNA enrichment from resected valves using the Molzym Ultra-Deep Microbiome Prep, sequencing of metagenomic libraries using the Illumina MiSeq platform, and Kraken 2 taxonomic assignments based on read data.Valve mNGS achieved a sensitivity of 82.4% and a specificity of 100% relative to the final adjudicated pathogen diagnosis. Blood culture, considered the reference standard, exhibited slightly higher sensitivity (88.2%) with comparable specificity (100%). In comparison, valve culture (sensitivity: 29.4%, specificity: 50.0%) and microscopy (sensitivity: 35.3%, specificity: 100%) showed lower diagnostic performance. Delays between blood culture negativization and valve resection impacted mNGS sensitivity, likely due to pathogen clearance. Notably, valves resected within 12 days from blood culture negativization achieved 100% diagnostic accuracy, emphasizing the importance of timing for optimal mNGS results.This study underscores mNGS as a valuable diagnostic tool for detecting IE pathogens, complementing traditional diagnostic methods. The detection of antibiotic resistance genes and multi-locus sequence typing profiles in some samples further demonstrated its utility.

    Keywords: cardiac surgery, clinical metagenomics, heart valve, microbiome, Next-generation sequencing

    Received: 21 Nov 2024; Accepted: 19 Feb 2025.

    Copyright: © 2025 Lazarevic, Gaïa, Pham, De Lorenzi-Tognon, Girard, Mauffrey, Charretier, Renzi, Huber and Schrenzel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Vladimir Lazarevic, Genomic Research Laboratory, Department of Medicine, Geneva University Hospitals (HUG) and University of Geneva, Geneva, Switzerland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more